ClinicalTrials.Veeva

Menu

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

University of Miami logo

University of Miami

Status

Enrolling

Conditions

Myeloproliferative Neoplasm
Lymphoma
Myeloma
Leukemia
Myelodysplastic Syndromes

Treatments

Other: LLS Program

Study type

Interventional

Funder types

Other

Identifiers

NCT05745285
20220784
20220220 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to learn about the impact that the services and programs provided by the Leukemia and Lymphoma Society have among patients with blood cancer, such as access to care, quality of life, and financial burden.

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Be currently receiving primary or relapse treatment for a diagnosis of leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN)
  • Report experiencing at least one unmet need addressed by the LLS Program (i.e., medical care including second opinions, travel for care, clinical trial access, financial and insurance needs, supportive programs, disease and treatment education)
  • Not be currently participating in any LLS programs or services
  • Be willing to be followed for 6 months
  • Speak English or Spanish

Exclusion criteria

  • Are not receiving primary or relapse treatment for a diagnosis of leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN)
  • Are not experiencing unmet needs addressed by the LLS Program (i.e., medical care including second opinions, travel for care, clinical trial access, financial and insurance needs, supportive programs, disease and treatment education)
  • Are currently participating in any LLS programs or services
  • Are not willing to be followed for 6 months
  • Do not speak English or Spanish.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

400 participants in 2 patient groups

LLS Program and Usual Care Group
Experimental group
Description:
Participants in the LLS Program and Usual Care condition will receive LLS services such as information, services, and financial aid so that patients can have better access to healthcare and better quality of life. Participants will also receive the standard care. Participants will be in this group for 6 months.
Treatment:
Other: LLS Program
Usual Care Group
No Intervention group
Description:
Participants will receive the standard care. Participants will be in this group for 6 months.

Trial contacts and locations

3

Loading...

Central trial contact

Magela Pons, BS; Carlos A Melara

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems